Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Trading in your spindles for blebs: the amoeboid tumor cell phenotype in prostate cancer.

Morley S, Hager MH, Pollan SG, Knudsen B, Di Vizio D, Freeman MR.

Asian J Androl. 2014 Jul-Aug;16(4):530-5. doi: 10.4103/1008-682X.122877.

PMID:
24589458
[PubMed - in process]
Free PMC Article
2.

Biology and proteomics of extracellular vesicles: harnessing their clinical potential.

D'Souza-Schorey C, Di Vizio D.

Expert Rev Proteomics. 2014 Jun;11(3):251-3. doi: 10.1586/14789450.2014.874290. Epub 2014 Jan 29.

PMID:
24476411
[PubMed - in process]
3.

Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.

Kim J, Morley S, Le M, Bedoret D, Umetsu DT, Di Vizio D, Freeman MR.

Cancer Biol Ther. 2014 Apr;15(4):409-18. doi: 10.4161/cbt.27627. Epub 2014 Jan 14.

PMID:
24423651
[PubMed - in process]
4.

PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.

Israelsen WJ, Dayton TL, Davidson SM, Fiske BP, Hosios AM, Bellinger G, Li J, Yu Y, Sasaki M, Horner JW, Burga LN, Xie J, Jurczak MJ, DePinho RA, Clish CB, Jacks T, Kibbey RG, Wulf GM, Di Vizio D, Mills GB, Cantley LC, Vander Heiden MG.

Cell. 2013 Oct 10;155(2):397-409. doi: 10.1016/j.cell.2013.09.025.

PMID:
24120138
[PubMed - indexed for MEDLINE]
5.

Large oncosomes mediate intercellular transfer of functional microRNA.

Morello M, Minciacchi VR, de Candia P, Yang J, Posadas E, Kim H, Griffiths D, Bhowmick N, Chung LW, Gandellini P, Freeman MR, Demichelis F, Di Vizio D.

Cell Cycle. 2013 Nov 15;12(22):3526-36. doi: 10.4161/cc.26539. Epub 2013 Sep 23.

PMID:
24091630
[PubMed - in process]
Free PMC Article
6.

Bladder tissue regeneration using acellular bi-layer silk scaffolds in a large animal model of augmentation cystoplasty.

Tu DD, Chung YG, Gil ES, Seth A, Franck D, Cristofaro V, Sullivan MP, Di Vizio D, Gomez P 3rd, Adam RM, Kaplan DL, Estrada CR Jr, Mauney JR.

Biomaterials. 2013 Nov;34(34):8681-9. doi: 10.1016/j.biomaterials.2013.08.001. Epub 2013 Aug 13.

PMID:
23953839
[PubMed - indexed for MEDLINE]
7.

Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.

Mukhopadhyay NK, Kim J, You S, Morello M, Hager MH, Huang WC, Ramachandran A, Yang J, Cinar B, Rubin MA, Adam RM, Oesterreich S, Di Vizio D, Freeman MR.

Oncogene. 2014 Jun 19;33(25):3235-45. doi: 10.1038/onc.2013.294. Epub 2013 Jul 29.

PMID:
23893242
[PubMed - in process]
Free PMC Article
8.

Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.

Majumdar S, Gong EM, Di Vizio D, Dreyfuss J, Degraff DJ, Hager MH, Park PJ, Bellmunt J, Matusik RJ, Rosenberg JE, Adam RM.

Neoplasia. 2013 Jul;15(7):749-60.

PMID:
23814487
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.

Ayala G, Morello M, Frolov A, You S, Li R, Rosati F, Bartolucci G, Danza G, Adam RM, Thompson TC, Lisanti MP, Freeman MR, Di Vizio D.

J Pathol. 2013 Sep;231(1):77-87. doi: 10.1002/path.4217. Epub 2013 Jul 8.

PMID:
23729330
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The impact of discrete modes of spinal cord injury on bladder muscle contractility.

Seth A, Chung YG, Kim D, Ramachandran A, Cristofaro V, Gomez P 3rd, Tu D, Huang L, Benowitz LI, Di Vizio D, Sullivan MP, Adam RM.

BMC Urol. 2013 May 13;13:24. doi: 10.1186/1471-2490-13-24.

PMID:
23668225
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The performance of silk scaffolds in a rat model of augmentation cystoplasty.

Seth A, Chung YG, Gil ES, Tu D, Franck D, Di Vizio D, Adam RM, Kaplan DL, Estrada CR Jr, Mauney JR.

Biomaterials. 2013 Jul;34(20):4758-65. doi: 10.1016/j.biomaterials.2013.03.038. Epub 2013 Mar 29.

PMID:
23545287
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, Moses MA, Demichelis F, Lisanti MP, Wu H, Klagsbrun M, Bhowmick NA, Rubin MA, D'Souza-Schorey C, Freeman MR.

Am J Pathol. 2012 Nov;181(5):1573-84. doi: 10.1016/j.ajpath.2012.07.030. Epub 2012 Sep 27.

PMID:
23022210
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network.

Kim J, Di Vizio D, Kim TK, Kim J, Kim M, Pelton K, Clinton SK, Hai T, Hwang D, Solomon KR, Freeman MR.

PLoS One. 2012;7(7):e39448. doi: 10.1371/journal.pone.0039448. Epub 2012 Jul 2. Erratum in: PLoS One. 2012;7(8). doi:10.1371/annotation/b77e9022-f87c-4f77-9f82-9072351e3360.

PMID:
22768301
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.

Liu Z, Zanata SM, Kim J, Peterson MA, Di Vizio D, Chirieac LR, Pyne S, Agostini M, Freeman MR, Loda M.

Oncogene. 2013 Mar 28;32(13):1660-9. doi: 10.1038/onc.2012.188. Epub 2012 Jun 18.

PMID:
22710717
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.

Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, Solomon KR, Adam RM, Isaacs WB, Higgs HN, Vessella RL, Di Vizio D, Freeman MR.

EMBO Mol Med. 2012 Aug;4(8):743-60. doi: 10.1002/emmm.201200242. Epub 2012 May 16.

PMID:
22593025
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Caveolin-1 and prostate cancer progression.

Freeman MR, Yang W, Di Vizio D.

Adv Exp Med Biol. 2012;729:95-110. doi: 10.1007/978-1-4614-1222-9_7. Review.

PMID:
22411316
[PubMed - indexed for MEDLINE]
17.

A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death.

Freeman MR, Kim J, Lisanti MP, Di Vizio D.

Cancer Biol Ther. 2011 Dec 1;12(11):966-77. doi: 10.4161/cbt.12.11.18136. Epub 2011 Dec 1.

PMID:
22108021
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The effect of manipulation of silk scaffold fabrication parameters on matrix performance in a murine model of bladder augmentation.

Gomez P 3rd, Gil ES, Lovett ML, Rockwood DN, Di Vizio D, Kaplan DL, Adam RM, Estrada CR Jr, Mauney JR.

Biomaterials. 2011 Oct;32(30):7562-70. doi: 10.1016/j.biomaterials.2011.06.067. Epub 2011 Jul 20.

PMID:
21764119
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evaluation of gel spun silk-based biomaterials in a murine model of bladder augmentation.

Mauney JR, Cannon GM, Lovett ML, Gong EM, Di Vizio D, Gomez P 3rd, Kaplan DL, Adam RM, Estrada CR Jr.

Biomaterials. 2011 Jan;32(3):808-18. doi: 10.1016/j.biomaterials.2010.09.051. Epub 2010 Oct 15.

PMID:
20951426
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Ezetimibe reduces enlarged prostate in an animal model of benign prostatic hyperplasia.

Pelton K, Di Vizio D, Insabato L, Schaffner CP, Freeman MR, Solomon KR.

J Urol. 2010 Oct;184(4):1555-9. doi: 10.1016/j.juro.2010.05.083. Epub 2010 Aug 21.

PMID:
20728125
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk